References
- Xie L, Evangelidis T, Xie L, Bourne PE. Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir. PLoS Comput. Biol.7(4), e1002037 (2011).
- Xie L, Bourne PE. A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites. BMC Bioinformatics8(Suppl. 4), S9 (2007).
- Xie L, Wang J, Bourne PE. In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators. PLoS Comput. Biol.3(11), e217 (2007).
- Xie L, Li J, Xie L, Bourne PE. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput. Biol.5(5), e1000387 (2009).
- Kinnings SL, Liu N, Buchmeier N, Tonge PJ, Xie L, Bourne PE. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol.5(7), e1000423 (2009).
- Brüning A, Gingelmaier A, Friese K, Mylonas I. New prospects for nelfinavir in non-HIV-related diseases. Curr. Mol. Pharmacol.3(2), 91–97 (2010).
- Kaldor SW, Kalish VJ, Davies JF 2nd et al. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. Med. Chem.40(24), 3979–3985 (1997).
- Blair JA, Rauh D, Kung C et al. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat. Chem. Biol.3(4), 229–238 (2007).
- Gills JJ, Lopiccolo J, Tsurutani J et al. Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin. Cancer Res.13(17), 5183–9514 (2007).
- Xie L, Xie L, Bourne PE. Structure-based systems biology for analyzing off-target binding. Curr. Opin. Struct. Biol.21(2), 189–199 (2011).
- Van der Schyf CJ. The use of multi-target drugs in the treatment of neurodegenerative diseases. Expert Rev. Clin. Pharmacol.4(3), 293–298 (2011).
- Yung HW, Charnock-Jones DS, Burton GJ. Regulation of AKT phosphorylation at Ser473 and Thr308 by endoplasmic reticulum stress modulates substrate specificity in a severity dependent manner. PLoS One.6(3), e17894 (2011).
- Boran AD, Iyengar R. Systems approaches to polypharmacology and drug discovery. Curr. Opin. Drug Discov. Devel.13(3), 297–309 (2010).
- Pérot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov. Today15(15–16), 656–667 (2010).
- Haupt VJ, Schroeder M. Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief Bioinform.12(4), 312–326 (2011).
Websites
- RCSD Protein Data Bank www.pdb.org
- Functional Site Analysis Resources http://funsite.sdsc.edu/scb
- National Biomedical Computational Resource www.nbcr.net